Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative fexofenadine for pain and trismus after mandibular impacted third molar surgery
IRCT20250202064596N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fexofenadine in postoperative pain and trismus, sponsored by Islamic Azad University. Primary endpoints: Acute postoperative pain and Postoperative trismus. Started Mar 2025; status: completed.
02
Drugs
fexofenadine
03
Conditions
postoperative paintrismus
Beyond the preview
Go deeper on IRCT20250202064596N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250202064596N1.